592 related articles for article (PubMed ID: 20719479)
1. Design and ocular tolerance of flurbiprofen loaded ultrasound-engineered NLC.
Gonzalez-Mira E; Egea MA; Garcia ML; Souto EB
Colloids Surf B Biointerfaces; 2010 Dec; 81(2):412-21. PubMed ID: 20719479
[TBL] [Abstract][Full Text] [Related]
2. Optimizing flurbiprofen-loaded NLC by central composite factorial design for ocular delivery.
Gonzalez-Mira E; Egea MA; Souto EB; Calpena AC; García ML
Nanotechnology; 2011 Jan; 22(4):045101. PubMed ID: 21169662
[TBL] [Abstract][Full Text] [Related]
3. Potential use of nanostructured lipid carriers for topical delivery of flurbiprofen.
González-Mira E; Nikolić S; García ML; Egea MA; Souto EB; Calpena AC
J Pharm Sci; 2011 Jan; 100(1):242-51. PubMed ID: 20575052
[TBL] [Abstract][Full Text] [Related]
4. Nanostructured lipid carriers (NLC) based topical gel of flurbiprofen: design, characterization and in vivo evaluation.
Han F; Yin R; Che X; Yuan J; Cui Y; Yin H; Li S
Int J Pharm; 2012 Dec; 439(1-2):349-57. PubMed ID: 22989987
[TBL] [Abstract][Full Text] [Related]
5. Optimization and physicochemical characterization of a triamcinolone acetonide-loaded NLC for ocular antiangiogenic applications.
Araújo J; Gonzalez-Mira E; Egea MA; Garcia ML; Souto EB
Int J Pharm; 2010 Jun; 393(1-2):167-75. PubMed ID: 20362042
[TBL] [Abstract][Full Text] [Related]
6. Design and optimization of NSAID loaded nanoparticles.
Sashmal S; Mukherjee S; Ray S; Thakur RS; Ghosh LK; Gupta BK
Pak J Pharm Sci; 2007 Apr; 20(2):157-62. PubMed ID: 17416573
[TBL] [Abstract][Full Text] [Related]
7. Improved and safe transcorneal delivery of flurbiprofen by NLC and NLC-based hydrogels.
Gonzalez-Mira E; Nikolić S; Calpena AC; Egea MA; Souto EB; García ML
J Pharm Sci; 2012 Feb; 101(2):707-25. PubMed ID: 22012873
[TBL] [Abstract][Full Text] [Related]
8. Feasibility of lipid nanoparticles for ocular delivery of anti-inflammatory drugs.
Souto EB; Doktorovova S; Gonzalez-Mira E; Egea MA; Garcia ML
Curr Eye Res; 2010 Jul; 35(7):537-52. PubMed ID: 20597640
[TBL] [Abstract][Full Text] [Related]
9. Encapsulation of ascorbyl palmitate in nanostructured lipid carriers (NLC)--effects of formulation parameters on physicochemical stability.
Teeranachaideekul V; Müller RH; Junyaprasert VB
Int J Pharm; 2007 Aug; 340(1-2):198-206. PubMed ID: 17482778
[TBL] [Abstract][Full Text] [Related]
10. Optimizing SLN and NLC by 2(2) full factorial design: effect of homogenization technique.
Severino P; Santana MH; Souto EB
Mater Sci Eng C Mater Biol Appl; 2012 Aug; 32(6):1375-9. PubMed ID: 24364934
[TBL] [Abstract][Full Text] [Related]
11. Polyhydroxy surfactants for the formulation of lipid nanoparticles (SLN and NLC): effects on size, physical stability and particle matrix structure.
Kovacevic A; Savic S; Vuleta G; Müller RH; Keck CM
Int J Pharm; 2011 Mar; 406(1-2):163-72. PubMed ID: 21219990
[TBL] [Abstract][Full Text] [Related]
12. Nanostructured lipid carrier (NLC) coated with Chitosan Oligosaccharides and its potential use in ocular drug delivery system.
Luo Q; Zhao J; Zhang X; Pan W
Int J Pharm; 2011 Jan; 403(1-2):185-91. PubMed ID: 20951778
[TBL] [Abstract][Full Text] [Related]
13. Flurbiprofen loaded biodegradable nanoparticles for ophtalmic administration.
Vega E; Egea MA; Valls O; Espina M; García ML
J Pharm Sci; 2006 Nov; 95(11):2393-405. PubMed ID: 16886193
[TBL] [Abstract][Full Text] [Related]
14. Minoxidil-loaded nanostructured lipid carriers (NLC): characterization and rheological behaviour of topical formulations.
Silva AC; Santos D; Ferreira DC; Souto EB
Pharmazie; 2009 Mar; 64(3):177-82. PubMed ID: 19348340
[TBL] [Abstract][Full Text] [Related]
15. Physical and chemical stability of nanostructured lipid drug carriers (NLC) based on natural lipids from Baikal region (Siberia, Russia).
Averina ES; Müller RH; Popov DV; Radnaeva LD
Pharmazie; 2011 May; 66(5):348-56. PubMed ID: 21699068
[TBL] [Abstract][Full Text] [Related]
16. Design, characterization, and in vitro cellular inhibition and uptake of optimized genistein-loaded NLC for the prevention of posterior capsular opacification using response surface methodology.
Zhang W; Li X; Ye T; Chen F; Sun X; Kong J; Yang X; Pan W; Li S
Int J Pharm; 2013 Sep; 454(1):354-66. PubMed ID: 23876384
[TBL] [Abstract][Full Text] [Related]
17. Nanostructured lipid carriers (NLC) on the basis of Siberian pine (Pinus sibirica) seed oil.
Averina ES; Seewald G; Müller RH; Radnaeva LD; Popov DV
Pharmazie; 2010 Jan; 65(1):25-31. PubMed ID: 20187575
[TBL] [Abstract][Full Text] [Related]
18. Preparation and characterization of nanostructured lipid carriers loaded traditional Chinese medicine, zedoary turmeric oil.
Zhao XL; Yang CR; Yang KL; Li KX; Hu HY; Chen DW
Drug Dev Ind Pharm; 2010 Jul; 36(7):773-80. PubMed ID: 20136496
[TBL] [Abstract][Full Text] [Related]
19. Nanostructured lipid carriers constituted from high-density lipoprotein components for delivery of a lipophilic cardiovascular drug.
Zhang WL; Gu X; Bai H; Yang RH; Dong CD; Liu JP
Int J Pharm; 2010 May; 391(1-2):313-21. PubMed ID: 20214958
[TBL] [Abstract][Full Text] [Related]
20. Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC).
Fang JY; Fang CL; Liu CH; Su YH
Eur J Pharm Biopharm; 2008 Oct; 70(2):633-40. PubMed ID: 18577447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]